Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

FDA Grants Final Approval For Epiduo Gel And Estrace Cream Generics

By Mike Botta | January 26, 2018

Perrigo Company plc received final approval from the U.S. Food and Drug Administration and has launched an AB-rated generic version of Epiduo (adapalene and benzoyl peroxide) Gel, 0.1%/2.5%, indicated for the topical treatment of acne vulgaris in patients 9 years of age and older. 

The company also received final FDA approval for the generic version of Estrace Cream (estradiol vaginal cream, USP, 0.01%), a product that will be marketed by Perrigo’s partner, Impax Laboratories, Inc., and is currently expected to launch in the second quarter of this year. Estrace Cream is indicated in the treatment of moderate to severe symptoms of vulvar and vaginal atrophy due to menopause.

Market sales of Epiduo Gel over the last 12 months were approximately $164 million, according to IMS Health, which placed market sales of Estrace Cream during the same period at approximately $457 million.

Perrigo Company plc was founded in 1887 as a packager of home remedies and has built a unique business model that is described as the convergence of a fast-moving consumer goods company, a high-quality pharmaceutical manufacturing organization, and a supply chain network.

The company is one of the world’s largest manufacturers of over-the-counter (OTC) healthcare products and suppliers of infant formulas for the store brand market. It also is a provider of branded OTC products throughout Europe and the U.S., as well as a producer of “extended topical” prescription drugs.

Perrigo, headquartered in Ireland, sells its products in North America and Europe, as well as in other markets, including Australia, Israel, and China.

(Source: Perrigo Company plc for Epiduo Gel and Estrace Cream)


Filed Under: Drug Discovery

 

Related Articles Read More >

Lokavant’s Spectrum v15 uses AI to cut trial-feasibility modeling from weeks to minutes
Prime time for peptide-based drug discovery 
Why smaller, simpler molecular glues are gaining attention in drug discovery
Glass vial, pipette and woman scientist in laboratory for medical study, research or experiment. Test tube, dropper and professional female person with chemical liquid for pharmaceutical innovation
Unlocking ‘bench-to-bedside’ discoveries requires better data sharing and collaboration
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE